Drug intelligence / Profile preview

Herpecin L

Development stage
Unknown
Lead developer
Focus Consumer Healthcare
Modality
Small Molecules
Administration
Topical
01

Overview

Herpecin L is a topical lip balm formulation developed by Focus Consumer Healthcare for the treatment and prevention of cold sores and fever blisters caused by the herpes simplex virus. The product functions as a multi-ingredient combination therapy, utilizing dimethicone (1%) as a skin protectant to provide a physical barrier and relieve dryness, alongside chemical sunscreens including meradimate (5%), octinoxate (7.5%), and oxybenzone (6%) to provide SPF 30 protection. This sun protection is critical as ultraviolet radiation is a common trigger for the reactivation of latent herpes simplex virus. Additionally, the formulation incorporates lysine hydrochloride, lemon balm (Melissa officinalis) extract, and vitamins C, B6, and E to support skin health and symptom relief. It is intended for both daily preventive use and acute treatment at the first sign of an outbreak to reduce healing time and symptom severity.

Brand names
Herpecin LHerpecin L Everyday Protection

Beyond the preview

Go deeper on Herpecin L.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpecin L.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call